You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FAV00A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-FLUMOS0116-00-VP( FLUMos-v2))

Recruiting
  • Influenza
  • VRC-FLUMOS0116-00-VP( FLUMos-v2)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 4, 2023

Cataract Trial in Trieste (ICB00 IOL, ZCB00 IOL, CNA0T0 IOL)

Completed
  • Cataract
  • ICB00 IOL
  • +2 more
  • Trieste, Friuli Venezia Giulia, Italy
    University Eye Clinic of Trieste
Oct 31, 2023

Technology Trial in Hong Kong (The dysphagia cups)

Not yet recruiting
  • Technology
  • The dysphagia cups
  • Hong Kong, Hong Kong
  • +5 more
Apr 4, 2023

Technology, Cognitive Impairments, Intellectual Disability Trial in Hong Kong (Tablet-based interactive games experimental group

Not yet recruiting
  • Technology
  • +2 more
  • Tablet-based interactive games experimental group intervention
  • Hong Kong, Hong Kong
  • +4 more
Apr 18, 2023

Technology Trial in Hong Kong (The resident-handling device)

Not yet recruiting
  • Technology
  • The resident-handling device
  • Hong Kong, Hong Kong
  • +2 more
Mar 16, 2023

Dengue Fever Trial in Dhaka (Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution)

Recruiting
  • Dengue Fever
  • Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Oct 5, 2023

Diabetes, Type 2 Trial in Czechia, Thailand (Insulin Icodec, Semaglutide)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Broumov, Czechia
  • +7 more
Apr 3, 2023

Technology Trial in Hong Kong (Experimental group intervention, Wait-list control group intervention)

Not yet recruiting
  • Technology
  • Experimental group intervention
  • Wait-list control group intervention
  • Hong Kong, Hong Kong
  • +1 more
Mar 2, 2023

HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-HIVMAB0115-00-AB)

Recruiting
  • HIV
  • VRC-HIVMAB0115-00-AB
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)

Completed
  • HIV Antibodies
  • VRC-HIVMAB091-00-AB
  • EDP
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 8, 2022

Cataract, Presbyopia Trial (Juvene IOL, Tecnis® Monofocal (ZCB00, PCB00 or DCB00))

Not yet recruiting
  • Cataract
  • Presbyopia
  • Juvene IOL
  • Tecnis® Monofocal (ZCB00, PCB00 or DCB00)
  • (no location specified)
May 10, 2022

Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)

Completed
Has Results
  • Ebola Virus
  • cAd3-EBO S vaccine
  • Kampala, Uganda
    Makerere University-Walter Reed Project
Nov 10, 2022

Malaria Trial in Baltimore (VRC-MALMAB0100-00-AB, CHMI)

Completed
  • Malaria
  • Baltimore, Maryland
    University of Maryland Baltimore, Center for Vaccine Development
Nov 9, 2022

Diabetes, Type 1, Diabetes, Type 2, Functional Dyspepsia Trial in Ostrava, Prague

Recruiting
  • Diabetes Mellitus, Type 1
  • +4 more
    • Ostrava, Czechia
    • +1 more
    Oct 3, 2023

    MDD Co-Occurrent With Anxiety, Adult Patients, Newly Diagnosed Depression Trial in Czechia

    Recruiting
    • Major Depressive Disorder Co-Occurrent With Anxiety
    • +2 more
      • Brno, Czechia
      • +5 more
      Jan 31, 2023

      Coagulation Status of Pregnant Peripartum Period Using Device

      Recruiting
      • Coagulation and Hemorrhagic Disorders
      • Coagulation test on device ClotPro
      • Brno, Czechia
        University Hospital Brno
      Jul 5, 2023

      Rehabilitation on Equal Terms - The ReMig Study

      Recruiting
      • Breast Cancer
      • Breast Neoplasms
        • Lund, Sweden
          Lund University, Skåne university hospital, Helsingborgs sjukhus
        Jan 18, 2023

        Duct Dependent Lesions, Necrotising Enterocolitis, Death Trial in Warsaw (enteral feeding as per predefined protocol)

        Not yet recruiting
        • Duct Dependent Lesions
        • +3 more
        • enteral feeding as per predefined protocol
        • Warsaw, Poland
        • +1 more
        Jul 16, 2022

        Influenza Trial run by the NIAID (VRC-FLUNPF0103-00-VP VRC-FLUNPF0103-00-VP (H10ssF-6473))

        Active, not recruiting
        • Influenza
        • VRC-FLUNPF0103-00-VP VRC-FLUNPF0103-00-VP (H10ssF-6473)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Mar 9, 2022

        Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)

        Active, not recruiting
        • Plasmodium Falciparum Infection
        • Malaria
        • VRC-MALMAB0100-00-AB (CIS43LS)
        • Normal saline
        • Kalifabougou, Région De Koulikoro, Mali
        • +1 more
        Sep 20, 2022

        Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

        Active, not recruiting
        • Myelodysplastic Syndrome (MDS)
        • Brasschaat, Belgium
        • +9 more
        Jan 19, 2023

        Marburg Virus Disease Trial in Silver Spring (cAd3-Marburg vaccine)

        Completed
        Has Results
        • Marburg Virus Disease
        • cAd3-Marburg vaccine
        • Silver Spring, Maryland
          WRAIR Clinical Trials Center,
        Aug 9, 2022

        Atrial Fibrillation Trial in Warsaw (Antazoline, Propafenone)

        Recruiting
        • Atrial Fibrillation
        • Warsaw, Poland
          Postgraduate Medical School
        Feb 12, 2023

        Neoadjuvant, Immunotherapy, Sarcoma,Soft Tissue Trial in Warsaw (Pembrolizumab, Eftilagimod alpha)

        Recruiting
        • Neoadjuvant
        • +3 more
        • Pembrolizumab, Eftilagimod alpha
        • Warsaw, Poland
          Maria Sklodowska-Curie National Research Institute of Oncology
        Nov 7, 2023

        Breast Cancer Trial in Beijing (oral vinorelbine and capecitabine)

        Recruiting
        • Breast Cancer
        • oral vinorelbine and capecitabine
        • Beijing, Beijing, China
          National Cancer Center/National Clinical Research Center for Can
        Feb 27, 2023